Related content

Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck

By Wagenblast   Hirth   Eckardt   Leinung   Diensthuber   Stöver   Hambek  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 286-290

Spandidos Publications

Access to resources Recommend Favorite

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

By Lathers D.M.R.   Achille N.J.   Young M.R.I.  

Human Immunology, Vol. 64, Iss. 12, 2003-12 ,pp. : 1160-1166

Elsevier

Access to resources Recommend Favorite

Molecular-targeted therapy hypoxia in head and neck squamous cell carcinoma patients (Review)

By Adachi   Thomas  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 12-14

Spandidos Publications

Access to resources Recommend Favorite

Immunological Approach in the Evaluation of Regional Lymph Nodes of Patients with Squamous Cell Carcinoma of the Head and Neck

By Verastegui E.   Morales R.   Barrera J.L.   Müeller A.   Hadden J.   Guzman B.   Meneses A.   Alfaro G.  

Clinical Immunology, Vol. 102, Iss. 1, 2002-01 ,pp. : 37-47

Academic Press

Access to resources Recommend Favorite

Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment

By  

The Journal Of Pathology: Clinical Research, Vol. 2, Iss. 2, 2016-04 ,pp. : 104-112

John Wiley & Sons Inc

Access to resources Recommend Favorite